跳至主要内容
临床试验/ITMCTR1900025303
ITMCTR1900025303招募中1 期

A multicenter randomized controlled trial for Shi-Xiao-San Powder and Er-Zhi-Wan Pill in the treatment of primary biliary cirrhosis

onghua Hospital, Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • (1) signing the informed consent;
  • (2) male or female aged 18-65 years;
  • (3) the syndrome differentiation of traditional Chinese medicine is liver kidney yin deficiency, blood stasis blocking collaterals;
  • (4) patients whose clinical diagnosis of Western medicine conforms to the PBC diagnostic standard and belongs to stage II and III;

排除标准

  • (1) Combined with drug-induced liver injury, autoimmune hepatitis A, B, C, e, etc.;
  • (2) patients with serious primary diseases of heart, brain, kidney, lung, endocrine, blood, metabolism and gastrointestinal tract, or psychosis;
  • (3) creatinine (CR) is higher than the upper limit of normal value;
  • (4) those who use drugs to lose weight;
  • (5) an alcoholic or drug addict;
  • (6) pregnant women, lactating women or those who prepare for pregnancy in the near future and those who use estrogen for contraception;
  • (7) those who are allergic to a variety of drugs, this medicine or its components;
  • (8) the patient is in critical condition, and it is difficult to make accurate evaluation on the effectiveness and safety of the new drug;
  • (9) patients are not willing to cooperate.

研究者

发起方
onghua Hospital, Shanghai University of Traditional Chinese Medicine

相似试验